2-(4-(Ethylsulfonyl)-2-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Catalog No. :
ACJFMV435
CAS No. :
1614246-36-4
Molecular Formula :
C15H23BO5S
Molecular Weight :
326.22

IUPAC Name:2-(4-(ethylsulfonyl)-2-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(4-(Ethylsulfonyl)-2-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$211.00Login to see priceInquiryInquiry
1g98%$526.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-(Ethylsulfonyl)-2-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
IUPAC Name2-(4-(ethylsulfonyl)-2-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
MDL No.MFCD30471061
Molecular FormulaC15H23BO5S
Molecular Weight326.22
SMILESCC1(C)C(C)(C)OB(C2=CC=C(S(=O)(CC)=O)C=C2OC)O1
InChI KeyMEPLIXQNGWBVBD-UHFFFAOYSA-N
Synonym2-(4-(ethylsulfonyl)-2-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;1,3,2-Dioxaborolane, 2-[4-(ethylsulfonyl)-2-methoxyphenyl]-4,4,5,5-tetramethyl-
CAS No.1614246-36-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACJFMV435 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJFMV435 route product structure diagram
    ACJFMV4351614246-36-4
Inquiry

2. ACJFMV435 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJFMV435 route product structure diagram
    ACJFMV4351614246-36-4
Inquiry

Comments (0)